What Hologic’s recent performance could mean for investors Hologic (HOLX) has been drawing fresh attention after a mix of modest short term moves and stronger past 3 months returns, prompting ...

Hologic is scheduled to release its first-quarter results soon, with analysts projecting single-digit growth in its bottom ...

Shares of Hologic HOLX closed the first trading session of the year at $74.56, which is quite close to the 52-week high of $75.34, reached on Dec. 15, 2025. In the past six months, the company has ...

Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. The study, conducted at Massachusetts General Hospital and ...

Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...

In the fourth quarter of fiscal 2025, Diagnostics revenues increased 1.5% in constant currency (CC), driven by higher core ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today launched Project Health Equality (PHE), a unique initiative that strives to address the ...